D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 50 Citations 9,326 120 World Ranking 2757 National Ranking 1315

Research.com Recognitions

Awards & Achievements

2017 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cytokine

His primary areas of study are Immunology, Natural killer T cell, CD1D, Cell biology and Antigen. As part of his studies on Immunology, Sebastian Joyce often connects relevant areas like Lineage. In his research, Cell culture, Synthetic antigen and Interleukin 15 is intimately related to Cell growth, which falls under the overarching field of Natural killer T cell.

He has included themes like Interleukin 12, Apolipoprotein E and Cytokine, Interleukin 4 in his CD1D study. His Cell biology study integrates concerns from other disciplines, such as Alpha, Cellular differentiation, T cell, Immune system and Negative selection. Sebastian Joyce works mostly in the field of Antigen, limiting it down to topics relating to Antigen presentation and, in certain cases, MHC class I.

His most cited work include:

  • Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice (1403 citations)
  • CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4 (565 citations)
  • Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol (374 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Antigen, Cell biology, Natural killer T cell and Immune system. His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Virology. His study looks at the intersection of Antigen and topics like Adjuvant with Ovalbumin, Dendritic cell, Immunization and Cancer immunotherapy.

His research integrates issues of Glycolipid, Transcription factor and INKT Cells in his study of Cell biology. His Natural killer T cell research is multidisciplinary, relying on both Receptor, Cell and Cytokine. His study focuses on the intersection of CD1D and fields such as CD1 with connections in the field of Lipid metabolism.

He most often published in these fields:

  • Immunology (67.40%)
  • Antigen (44.20%)
  • Cell biology (33.70%)

What were the highlights of his more recent work (between 2016-2020)?

  • Immunology (67.40%)
  • Natural killer T cell (34.81%)
  • Antigen (44.20%)

In recent papers he was focusing on the following fields of study:

Immunology, Natural killer T cell, Antigen, Adjuvant and Cell biology are his primary areas of study. He is interested in Immune system, which is a field of Immunology. Cytotoxic T cell covers Sebastian Joyce research in Natural killer T cell.

The various areas that he examines in his Antigen study include Cancer immunotherapy and Virology. He has researched Adjuvant in several fields, including CD8 and Immunogenicity. His Cell biology research includes elements of Cell growth and T-cell receptor.

Between 2016 and 2020, his most popular works were:

  • Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines. (31 citations)
  • Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines. (31 citations)
  • Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model. (30 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cytokine

Sebastian Joyce mainly focuses on Antigen, Adjuvant, Immunogenicity, Virology and Cancer immunotherapy. In general Antigen study, his work on MHC class I and Immunodominance often relates to the realm of Imidazoquinoline, thereby connecting several areas of interest. His MHC class I research incorporates elements of Ecology, Cytokine, Natural killer T cell, CD1D and Chemokine.

His Adjuvant study necessitates a more in-depth grasp of Immunology. His Virology research includes themes of Epitope and Immunity. His study looks at the relationship between CD8 and fields such as T cell, as well as how they intersect with chemical problems.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice

Mary K. Kennedy;Moira Glaccum;Sandra N. Brown;Eric A. Butz.
Journal of Experimental Medicine (2000)

1861 Citations

CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4

Sanjeev K Mendiratta;W.David Martin;Seokmann Hong;Alina Boesteanu.
Immunity (1997)

886 Citations

Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol

Sebastian Joyce;Amina S. Woods;Jonathan W. Yewdell;Jack R. Bennink.
Science (1998)

462 Citations

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis

Avneesh K. Singh;Michael T. Wilson;Seokmann Hong;Danyvid Olivares-Villagómez.
Journal of Experimental Medicine (2001)

442 Citations

Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways

Keunwook Lee;Prathyusha Gudapati;Srdjan Dragovic;Charles Spencer.
Immunity (2010)

442 Citations

Glycolipid antigen induces long-term natural killer T cell anergy in mice

Vrajesh V. Parekh;Michael T. Wilson;Danyvid Olivares-Villagómez;Avneesh K. Singh.
Journal of Clinical Investigation (2005)

422 Citations

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.

Michael T. Wilson;Cecilia Johansson;Danyvid Olivares-Villagómez;Avneesh K. Singh.
Proceedings of the National Academy of Sciences of the United States of America (2003)

352 Citations

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

Li Yang;Noboru Yamagata;Rajwardhan Yadav;Suzanne Brandon.
Journal of Clinical Investigation (2003)

286 Citations

CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection

Alison Motsinger;David W. Haas;Aleksandar K. Stanic;Luc Van Kaer.
Journal of Experimental Medicine (2002)

267 Citations

Natural killer T cells accelerate atherogenesis in mice.

Yukihito Nakai;Kazuya Iwabuchi;Satoshi Fujii;Naoki Ishimori.
Blood (2004)

250 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sebastian Joyce

Mitchell Kronenberg

Mitchell Kronenberg

La Jolla Institute For Allergy & Immunology

Publications: 115

Luc Van Kaer

Luc Van Kaer

Vanderbilt University

Publications: 87

Steven A. Porcelli

Steven A. Porcelli

Albert Einstein College of Medicine

Publications: 86

Gurdyal S. Besra

Gurdyal S. Besra

University of Birmingham

Publications: 77

Dale I. Godfrey

Dale I. Godfrey

University of Melbourne

Publications: 72

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 50

Mark A. Exley

Mark A. Exley

Brigham and Women's Hospital

Publications: 49

Albert Bendelac

Albert Bendelac

University of Chicago

Publications: 47

Chyung Ru Wang

Chyung Ru Wang

Northwestern University

Publications: 46

Masaru Taniguchi

Masaru Taniguchi

Chiba University

Publications: 46

Vincenzo Cerundolo

Vincenzo Cerundolo

University of Oxford

Publications: 46

Thomas A. Waldmann

Thomas A. Waldmann

National Institutes of Health

Publications: 45

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 43

Michael B. Brenner

Michael B. Brenner

Brigham and Women's Hospital

Publications: 38

James P. Di Santo

James P. Di Santo

Institut Pasteur

Publications: 37

Eric P. Skaar

Eric P. Skaar

Vanderbilt University Medical Center

Publications: 35

Something went wrong. Please try again later.